bf/NYSE:NVO_icon.jpeg

COM:NOVONORDISK

Novo Nordisk A/S

  • Stock

Last Close

105.27

21/11 21:00

Market Cap

628.74B

Beta: -

Volume Today

5.66M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
83.57B
-
88.81B
6.26%
107.93B
21.53%
111.78B
3.57%
111.70B
0.08%
111.83B
0.12%
122.02B
9.11%
126.95B
4.04%
140.80B
10.91%
176.95B
25.68%
232.26B
31.26%
cost of revenue
14.14B
-
14.56B
2.98%
16.19B
11.17%
17.18B
6.15%
17.63B
2.61%
17.62B
0.09%
20.09B
14.03%
20.93B
4.20%
23.66B
13.02%
28.45B
20.25%
35.77B
25.72%
gross profit
69.43B
-
74.24B
6.93%
91.74B
23.56%
94.60B
3.12%
94.06B
0.56%
94.21B
0.16%
101.93B
8.19%
106.01B
4.00%
117.14B
10.50%
148.51B
26.77%
196.50B
32.32%
selling and marketing expenses
23.38B
-
23.22B
0.67%
28.31B
21.91%
28.38B
0.23%
28.34B
0.13%
29.40B
3.73%
31.82B
8.25%
32.93B
3.47%
37.01B
12.39%
46.22B
24.88%
56.74B
22.78%
general and administrative expenses
3.51B
-
3.54B
0.83%
3.86B
9.05%
3.96B
2.72%
3.78B
4.49%
3.92B
3.49%
4.01B
2.32%
3.96B
1.22%
4.05B
2.32%
4.47B
10.30%
4.86B
8.69%
selling general and administrative expenses
26.89B
-
26.76B
0.48%
32.17B
20.21%
32.34B
0.53%
32.12B
0.66%
33.31B
3.70%
35.83B
7.56%
36.89B
2.95%
41.06B
11.31%
50.68B
23.44%
61.60B
21.53%
research and development expenses
11.73B
-
13.76B
17.29%
13.61B
1.12%
14.56B
7.02%
14.01B
3.77%
14.80B
5.64%
14.22B
3.95%
15.46B
8.73%
17.77B
14.94%
24.05B
35.31%
32.44B
34.91%
other expenses
-682M
-
-770M
12.90%
-3.48B
352.21%
-737M
78.83%
-1.04B
41.25%
-1.15B
10.66%
-600M
47.92%
-460M
23.33%
-332M
27.83%
-1.03B
211.45%
cost and expenses
52.08B
-
54.31B
4.29%
58.48B
7.68%
63.35B
8.32%
62.73B
0.98%
64.58B
2.96%
69.54B
7.67%
72.82B
4.72%
82.16B
12.82%
102.14B
24.33%
129.69B
26.96%
operating expenses
37.94B
-
39.75B
4.78%
42.30B
6.40%
46.16B
9.15%
45.10B
2.31%
46.97B
4.14%
49.45B
5.29%
51.89B
4.93%
58.50B
12.74%
73.70B
25.98%
93.92B
27.44%
interest expense
55M
-
563M
923.64%
6.05B
973.89%
65M
98.92%
90M
38.46%
85M
5.56%
220M
158.82%
390M
77.27%
2.45B
528.46%
378M
84.58%
542M
43.39%
ebitda
35.06B
-
38.09B
8.65%
52.49B
37.79%
51.62B
1.66%
52.16B
1.06%
51.16B
1.92%
57.79B
12.95%
60.22B
4.19%
67.56B
12.19%
82.04B
21.44%
112.94B
37.66%
operating income
31.49B
-
34.49B
9.52%
49.44B
43.35%
48.43B
2.05%
48.97B
1.10%
47.25B
3.51%
52.48B
11.08%
54.13B
3.13%
58.64B
8.35%
74.81B
27.56%
102.57B
37.11%
depreciation and amortization
2.80B
-
3.44B
22.72%
2.96B
13.86%
3.19B
7.91%
3.18B
0.34%
3.92B
23.35%
5.31B
35.24%
6.09B
14.71%
8.91B
46.36%
7.23B
18.86%
9.41B
30.18%
total other income expenses net
332M
-
-347M
204.52%
-5.87B
1,591.35%
-536M
90.87%
-198M
63.06%
473M
338.89%
-3.93B
930.87%
-996M
74.66%
436M
143.78%
-5.75B
1,418.12%
1.77B
130.80%
income before tax
32.54B
-
34.10B
4.79%
43.48B
27.53%
47.80B
9.92%
48.68B
1.85%
47.62B
2.19%
48.55B
1.97%
53.13B
9.43%
59.08B
11.20%
69.06B
16.90%
104.67B
51.57%
income tax expense
7.36B
-
7.62B
3.54%
8.62B
13.24%
9.87B
14.50%
10.55B
6.86%
8.99B
14.82%
9.60B
6.84%
10.99B
14.48%
11.32B
3.01%
13.54B
19.55%
20.99B
55.06%
net income
25.18B
-
26.48B
5.15%
34.86B
31.64%
37.92B
8.79%
38.13B
0.54%
38.63B
1.31%
38.95B
0.84%
42.14B
8.18%
47.76B
13.33%
55.52B
16.27%
83.68B
50.71%
weighted average shs out
2.68B
-
2.62B
2.15%
2.57B
1.95%
2.53B
1.59%
2.47B
2.24%
2.42B
2.17%
2.37B
1.87%
2.33B
1.70%
2.30B
1.60%
2.27B
1.36%
4.48B
97.89%
weighted average shs out dil
2.69B
-
2.63B
2.37%
2.58B
1.95%
2.53B
1.69%
2.48B
2.23%
2.42B
2.17%
2.38B
1.89%
2.34B
1.63%
2.30B
1.58%
2.27B
1.34%
4.49B
97.81%
eps
9.40
-
10.10
7.45%
13.56
34.26%
14.99
10.55%
15.42
2.87%
15.96
3.50%
16.41
2.82%
18.05
9.99%
20.79
15.18%
24.51
17.89%
18.67
23.83%
epsdiluted
9.35
-
10.07
7.70%
13.52
34.26%
14.96
10.65%
15.39
2.87%
15.93
3.51%
16.38
2.82%
18.01
9.95%
20.74
15.16%
24.44
17.84%
18.62
23.81%

All numbers in (except ratios and percentages)